Precious Metals

[gfp927z]

Blade, I saw your post on GMTX and wondered if you decided to invest? Also saw the bio newsletter post over on Dew's board (link below), and the author mentions 4 stocks involved in the dry macular space. Things looked great until seeing that 20% of the dry macular patients had flipped to 'wet' during treatment (compared to 1% in the placebo group).

Not sure if GMTX's drug will do better, but 20% of patients going wet is no laughing matter since the wet form is devastating. My mom had it, and after several years of Avastin and then Lucentis injections, she ultimately lost most of her vison over a 3 day period. She went from 20/80 to basically blind, what a nightmare. My dad had the dry form and luckily it stayed dry.

With the total lack of current treatments (other than vitamins/minerals), the GMTX drug could be a blockbuster if it can improve on that 20% risk aspect. I think that other drug was from Apellis Pharma -


https://mattbiotech.substack.com/p/4-the-geographic-atrophy-issue-apls


https://investorshub.advfn.com/boards/read_msg.aspx?message_id=161872601